Spyre Therapeutics Rings the Opening Bell
About This Event
Spyre Therapeutics (Nasdaq: SYRE), a biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations and precision medicine approaches for the treatment of inflammatory bowel disease (IBD), visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Cameron Turtle, Chief Executive Officer, rings the Opening Bell.